Navigation Links
Novel vaccine shows promise against early-stage breast cancer

A diagnosis of breast cancer has taken on a new meaning in the past 10 years, as research has produced a host of new therapies and detection techniques, significantly improving long-term survival for women who have been fighting the disease. To build on these successes, researchers are now harnessing what they have learned about treating breast cancer and applying it to possible methods of prevention to reduce the total incidence of the disease. One study presented today at the American Association for Cancer Research's Frontiers in Cancer Prevention Research meeting in Boston looks at a specific target in the fight against breast cancer and evaluates a potential vaccine that is yielding promising results for women who are at high-risk for the disease.

Targeted immunoediting of critical pathways responsible for breast cancer development: treatment of early breast cancer using HER-2/neu pulsed dendritic cells

Multiple genetic targets have been discovered that may help fight breast cancer, including BRCA, estrogen receptors, and HER-2/neu, all of which have been known to predict the severity of disease, recurrence and overall survival. Developing novel therapies that target these specific genetic variances may be extremely beneficial in preventing breast cancer for many women.

In this study, researchers investigated a potential vaccine that targets HER-2/neu over-expression in early stage breast cancer, known as DCIS (ductal carcinomas in situ, or early stage cancer formation in the breast's milk ducts). It is estimated at 50-60 percent of DCIS is directly related to HER-2/neu over-expression.

Patients with HER-2/neu overexpression were given a therapy of dendritic cells (DC, which work with the B- and T-cells to trigger immune responses) that were treated with HER-2/neu to evoke an immune response. The participants received four weekly vaccinations into normal lymph nodes in their groins and were evaluated both pre- and po
'"/>

Source:American Association for Cancer Research


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel vaccine shows promise against early stage breast cancer

(Date:3/23/2015)... 2015 SoundView Technology Group issues a new research ... ) Wocket smart wallet. SoundView was one of the selected user ... with the Wocket in multiple scenarios and outlets. ... other retailers, making both debit and credit card payments.  ... "If the company meets their plans in 2015, it would ...
(Date:3/23/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), a ... announces its biometric payment technology, the Wocket® smart wallet, will ... 30 th . The new 30 ... markets. Gino Pereira , ... ad campaign following the recent initial shipment of Wocket smart ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... is one of the products featured in 2015 "I ... at 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... 17, 2009 Representatives of the nation,s leading public ... and other Members of Congress, today announced the launch ... research and related activities that have been made possible ... (ARRA), also known as the stimulus. The ...
... be as intelligent as much bigger animals, despite only ... scientists at Queen Mary, University of London. "Animals ... to Lars Chittka, Professor of Sensory and Behavioural Ecology ... of Cambridge colleague, Jeremy Niven. This begs the important ...
... Two University of New Hampshire assistant professors ... Early Career Development (CAREER) grants. Vaughn Cooper of ... received $1 million to better understand beneficial mutations ... data collection. Christopher White of the mechanical engineering ...
Cached Biology News:Members of Congress, university leaders, scientists launch ScienceWorksForUS 2Members of Congress, university leaders, scientists launch ScienceWorksForUS 3Members of Congress, university leaders, scientists launch ScienceWorksForUS 4Bigger not necessarily better, when it comes to brains 22 UNH faculty receive $1.4M in CAREER grants from NSF 2
(Date:3/31/2015)... March 31, 2015 Today, Cryos International, ... relocation of their U.S. facilities and inventory from New ... years of experience, Cryos’ relocation is a reflection of ... move to Orlando was completed during the first weekend ... opening taking place on April 6. The new facility ...
(Date:3/30/2015)... 2015  Multiple new research abstracts suggest walnuts may ... factors. From their impact on colon cancer and certain ... both gut health and vascular health, the research findings ... understanding of walnuts, inner workings. Running March 28 through ... annual meeting attracts an international audience of over 14,000 ...
(Date:3/30/2015)... Md. , March 30, 2015 CASI ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a commercial focus on ... Food and Drug Administration (CFDA) has approved the Company,s ... in ovarian clear cell carcinoma (OCCC) patients for its ...
(Date:3/30/2015)... OXFORD, England , March 30, 2015 /PRNewswire/ ... company developing novel biological drugs to treat cancer, ... appointment of Professor Sir John Bell , ... and Chairman of the Office for the Strategic ... Directors with immediate effect.      (Photo: ...
Breaking Biology Technology:Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5
... Leading Suppliers for the Life ... Science Industries, ... company is finalizing discussions to acquire Bahamas-based,PharmaChem Technologies (Grand Bahama) Ltd ... responds to their shared,vision of becoming the leading global supplier for ...
... - Clinical Study Demonstrates Breakthrough Dose-Sparing Formulation,That ... Billions of Doses in a Pandemic Situation ... today,announced data showing that its new investigational H5N1 ... high immune response,at the lowest dose of H5N1 ...
... /Xinhua-PRNewswire/ -- Shandong Zhouyuan Seed,and Nursery Co., Ltd. ... is incorporated in the State of Delaware, announced,that ... Seed and,Nursery Co., Ltd. ("Zhouyuan" or "the Company"), ... Linyi Kun Yuan Seeds Co., Ltd. ("Kun Yuan") ...
Cached Biology Technology:Groupe Novasep to Acquire PharmaChem Technologies (Grand Bahama) Ltd 2Groupe Novasep to Acquire PharmaChem Technologies (Grand Bahama) Ltd 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 2Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 3